ABM Respiratory Care Secures $20 Million Financing from Trinity Capital to Accelerate Commercial Expansion
Key Highlights
- ➤ABM Respiratory Care secures $20 million growth capital commitment from Trinity Capital (TRIN)
- ➤Financing targets commercial expansion, product innovation, and clinical research
- ➤BiWaze platform includes two FDA-cleared respiratory therapy systems
- ➤Arc Connect digital platform supports patient engagement and therapy tracking
Expert Statements
Greg Miller, Chief Executive Officer of ABM Respiratory Care
“This financing represents an important milestone in ABM Respiratory Care's continued growth”
Greg Miller, Chief Executive Officer of ABM Respiratory Care
“Our partnership with Trinity Capital provides additional capital and flexibility to expand our commercial reach, build on the momentum of our BiWaze platform, and invest in technologies that support the evolving needs of patients and healthcare providers worldwide.”
Rob Lake, Senior Managing Director, Healthcare & Life Sciences at Trinity Capital
“We are pleased to partner with ABM Respiratory Care as the company enters its next phase of growth”
Rob Lake, Senior Managing Director, Healthcare & Life Sciences at Trinity Capital
“We believe in the company's technology and its vision for expanding access to respiratory care solutions.”
ABM Respiratory Care Secures $20 Million Financing from Trinity Capital to Accelerate Commercial Expansion PR Newswire
EAGAN, Minn., Oct. 20, 2026 /PRNewswire/ -- ABM Respiratory Care ("ABMRC"), a medical technology company developing innovative respiratory care solutions for hospital and home use, today announced that it has secured a $20 million growth capital commitment from Trinity Capital Inc. (NYSE: TRIN), an international alternative asset manager.
Get started
Create a free account to read the full story.